X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Novartis with Aurobindo Pharma - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

NOVARTIS vs AUROBINDO PHARMA - Comparison Results

NOVARTIS    Change

Novartis is a 76% subsidiary of Novartis AG - Switzerland and has a countrywide presence in the healthcare business. While pharmaceuticals contributes 70% to total revenues (FY10), generics (6%), consumer healthcare i.e. OTC (14%) and animal health (... More

AUROBINDO PHARMA 
   Change

Aurobindo Pharma is one of India's top 5 pharma companies in terms of turnover, and has presence in the generic and Active Pharmaceutical Ingredients (API) segments. The company's robust product portfolio is spread across 6 product areas, including a... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    NOVARTIS AUROBINDO PHARMA NOVARTIS/
AUROBINDO PHARMA
 
P/E (TTM) x 341.5 17.9 1,906.8% View Chart
P/BV x 16.8 5.8 288.9% View Chart
Dividend Yield % 1.7 0.4 481.9%  

Financials

 NOVARTIS   AUROBINDO PHARMA
EQUITY SHARE DATA
    NOVARTIS
Mar-16
AUROBINDO PHARMA
Mar-16
NOVARTIS/
AUROBINDO PHARMA
5-Yr Chart
Click to enlarge
High Rs9821,541 63.7%   
Low Rs556582 95.6%   
Sales per share (Unadj.) Rs252.9237.5 106.5%  
Earnings per share (Unadj.) Rs62.133.9 183.5%  
Cash flow per share (Unadj.) Rs63.340.6 156.0%  
Dividends per share (Unadj.) Rs10.002.50 400.0%  
Dividend yield (eoy) %1.30.2 552.0%  
Book value per share (Unadj.) Rs363.6120.6 301.5%  
Shares outstanding (eoy) m31.96585.17 5.5%   
Bonus/Rights/Conversions -PREF-  
Price / Sales ratio x3.04.5 68.0%   
Avg P/E ratio x12.431.3 39.5%  
P/CF ratio (eoy) x12.226.2 46.5%  
Price / Book Value ratio x2.18.8 24.0%  
Dividend payout %16.17.4 218.0%   
Avg Mkt Cap Rs m24,580621,041 4.0%   
No. of employees `0000.813.3 5.7%   
Total wages/salary Rs m1,80115,508 11.6%   
Avg. sales/employee Rs Th10,748.910,457.6 102.8%   
Avg. wages/employee Rs Th2,395.21,167.1 205.2%   
Avg. net profit/employee Rs Th2,641.11,491.6 177.1%   
INCOME DATA
Net Sales Rs m8,083138,961 5.8%  
Other income Rs m8291,663 49.9%   
Total revenues Rs m8,913140,624 6.3%   
Gross profit Rs m23432,056 0.7%  
Depreciation Rs m373,926 0.9%   
Interest Rs m22,568 0.1%   
Profit before tax Rs m1,02527,225 3.8%   
Minority Interest Rs m039 0.0%   
Prior Period Items Rs m170-   
Extraordinary Inc (Exp) Rs m1,6960-   
Tax Rs m7527,444 10.1%   
Profit after tax Rs m1,98619,820 10.0%  
Gross profit margin %2.923.1 12.6%  
Effective tax rate %73.427.3 268.3%   
Net profit margin %24.614.3 172.3%  
BALANCE SHEET DATA
Current assets Rs m12,678100,015 12.7%   
Current liabilities Rs m2,43374,759 3.3%   
Net working cap to sales %126.718.2 697.3%  
Current ratio x5.21.3 389.5%  
Inventory Days Days33107 30.4%  
Debtors Days Days22110 20.5%  
Net fixed assets Rs m6952,350 0.1%   
Share capital Rs m160585 27.3%   
"Free" reserves Rs m11,46067,707 16.9%   
Net worth Rs m11,62170,567 16.5%   
Long term debt Rs m08,472 0.0%   
Total assets Rs m14,400156,994 9.2%  
Interest coverage x570.511.6 4,916.8%   
Debt to equity ratio x00.1 0.0%  
Sales to assets ratio x0.60.9 63.4%   
Return on assets %13.814.3 96.8%  
Return on equity %17.128.1 60.8%  
Return on capital %23.637.7 62.5%  
Exports to sales %0.751.0 1.5%   
Imports to sales %18.618.8 98.6%   
Exports (fob) Rs m6070,927 0.1%   
Imports (cif) Rs m1,50326,193 5.7%   
Fx inflow Rs m18671,015 0.3%   
Fx outflow Rs m1,82128,799 6.3%   
Net fx Rs m-1,63542,216 -3.9%   
CASH FLOW
From Operations Rs m2,53117,596 14.4%  
From Investments Rs m-8,270-13,801 59.9%  
From Financial Activity Rs m-386-198 194.5%  
Net Cashflow Rs m-6,1253,597 -170.3%  

Share Holding

Indian Promoters % 0.0 54.1 -  
Foreign collaborators % 75.0 0.0 -  
Indian inst/Mut Fund % 2.0 8.0 25.2%  
FIIs % 1.6 27.7 5.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 21.5 10.2 210.8%  
Shareholders   41,647 69,601 59.8%  
Pledged promoter(s) holding % 0.0 8.6 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare NOVARTIS With:   DISHMAN PHARMA  ELDER PHARMA  ALEMBIC LTD  PANACEA BIOTECH  CADILA HEALTHCARE  

Compare NOVARTIS With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Trades on a Volatile Note; Energy Stocks Witness Buying(11:30 am)

After opening the day in green, Share markets in India witnessed volatile trading activity and are presently trading marginally above the dotted line.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

The Most Important Innovation in Finance Since Gold Coins(Vivek Kaul's Diary)

Aug 10, 2017

Bill connects the dots...between money and growth, real money and real resources, gold and cryptocurrencies...and between gold, cryptocurrencies, and time.

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

5 Steps To Become Financially Independent(Outside View)

Aug 16, 2017

Ensure your financial Independence, and pledge to start the journey towards financial freedom today!

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

NOVARTIS SHARE PRICE


Aug 22, 2017 01:23 PM

TRACK NOVARTIS

  • Track your investment in NOVARTIS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

NOVARTIS 8-QTR ANALYSIS

COMPARE NOVARTIS WITH

MARKET STATS